Skip to main content
SI
NYSE Industrial Applications And Services

Shoulder Innovations Files $300M Shelf and Registers 8.1M Share Resale by Insiders and Major Holders

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$20.59
Mkt Cap
$427M
52W Low
$10.92
52W High
$24.595
52W Position info
89% above low
Off High info
16% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

SI sits 89% above its 52-week low of $10.92 on elevated volume (2.4× avg).

Summary

Shoulder Innovations filed a $300M mixed shelf and registered 8.1M shares for resale by insiders and major venture capital holders, creating potential selling pressure on the stock.


Key Events · Financing and Capital Events · SI

  • $300M Mixed Shelf Filed

    The company registers up to $300 million in common stock, preferred stock, debt securities, warrants, subscription rights, and units for future sale.

  • 8.1M Share Resale Registration

    Selling stockholders, including CEO Robert Ball, COO Matthew Ahearn, and venture capital firms Gilde Healthcare, Lightstone Ventures, and US Venture Partners, register 8,103,026 shares for resale—approximately 39% of the 20.76M shares outstanding.

  • Insider and Major Holder Liquidity

    CEO Ball registers 66,225 shares, COO Ahearn registers 117,047 shares; Gilde Healthcare registers 2,280,482 shares, Lightstone Ventures entities register 1,618,470 shares, and US Venture Partners entities register 2,693,119 shares.

  • No Immediate Dilution from Shelf

    The shelf registration provides capacity for future offerings but does not itself issue shares; actual dilution will occur only upon a subsequent prospectus supplement and sale.


Analysis · SI · Industrial Applications And Services

A $300 million mixed shelf registration gives Shoulder Innovations the flexibility to raise capital through a variety of securities. More immediately, the filing registers the resale of 8.1 million shares—about 39% of the outstanding float—by selling stockholders including CEO Robert Ball, COO Matthew Ahearn, and major venture capital holders Gilde Healthcare, Lightstone Ventures, and US Venture Partners. While no shares have been sold yet, the registration clears the way for significant insider and institutional selling, creating a potential overhang on the stock. The company recently posted strong Q2 revenue growth of 56% and expanded gross margins to 78.3%, but operating losses widened to $10 million. The shelf and resale registration come just one week after that earnings report, suggesting the company and its backers are positioning to access capital markets or provide liquidity to early investors.

At the time of this filing, SI was trading at $20.59 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $427M. The 52-week trading range was $10.92 to $24.60. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SI - Latest Insights

SI
Aug 06, 2026, 5:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $22.43
Real-time Price: $20.59 info
Change: -$1.84 (-8%) info
Market Cap: $427M info
SI
Aug 06, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $22.43
Real-time Price: $20.59 info
Change: -$1.84 (-8%) info
Market Cap: $427M info
SI
Jun 29, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.00
Real-time Price: $20.59 info
Change: -$1.41 (-6%) info
Market Cap: $427M info
SI
May 13, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.42
Real-time Price: $20.59 info
Change: +$6.17 (+43%) info
Market Cap: $427M info
SI
May 13, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.42
Real-time Price: $20.59 info
Change: +$6.17 (+43%) info
Market Cap: $427M info